TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMUX

Immunic Inc

Healthcare · Biotechnology

8.00$ -7.9% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IMUX
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – 100.0% – – – – – – – – –
– – – – – 3.4% – – – – – – – – –
– – – – – 96.6% – – – – – – – – –
– – – – – 500,766.7% – – – – – – – – –
– – – – – 187,000.0% – – – – – – – – –
– – – – – 687,766.7% – – – – – – – – –
– – – – – -687,766.7% – – – – – – – – –
– – – – – 0.0% – – – – – – – – –
– – – – – -682,816.7% – – – – – – – – –
– – – – – -30,133.3% – – – – – – – – –
– – – – – -682,816.7% – – – – – – – – –
– – – – – -657,633.3% – – – – – – – – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?